Skip to main content
SpringerLink
Log in

The potential of selected South African plants with anti-Klebsiella activity for the treatment and prevention of Ankylosing spondylitis

Inflammopharmacology volume 23, pages 21–35 (2015)Cite this article

Abstract

A wide variety of herbal remedies are used in traditional African medicine to treat inflammatory disorders, including some autoimmune diseases. Thirty-four extracts from 13 South African plant species traditionally used for the treatment of inflam mation were investigated for their ability to control a microbial trigger for ankylosing spondylitis (Klebsiella pneumoniae). Twenty-six of the extracts (76.5 %) inhibited the growth of K. pneumoniae. Methanol and water extracts of Ballota africana, Carpobrotus edulis leaves, Kigellia africana, Lippia javanica, Pelargonium fasiculata, Syzygium cordatum (including bark), Terminalia pruinoides and Terminalia sericea were effective K. pneumoniae inhibitors, with MIC values <1000 µg/ml. The roots of Tulbaghia violaceae and bark from Warburgia salutaris also demonstrated efficacy. The most potent extracts were examined by RP-HPLC and UV–Vis spectroscopy for the presence of resveratrol. Methanolic extracts of B. africana, C. edulis leaves, L. javanica, T. pruinoides and T. sericea, as well as aqueous B. africana, T. pruinoides and T. sericea extracts, displayed peaks with retention times and UV–Vis spectra consistent with the presence of resveratrol. Resveratrol was generally a minor component, indicating that resveratrol was not solely responsible for the anti-Klebsiella growth inhibitory properties. Plant extracts with K. pneumoniae inhibitory activity were either non-toxic, or of low toxicity in the Artemia (brine shrimp) nauplii bioassay. Their low toxicity and antibiotic bioactivity against K. pneumoniae indicate their potential for both preventing the onset of ankylosing spondylitis and minimising its symptoms once the disease is established.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  • Alataha D, Kapral T, Smolen JS (2003) Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. Ann Rheum Dis 62:482–486

    Article  Google Scholar 

  • Ashayeri-Panah M, Feizabadi MM, Eftekhar F (2014) Correlation of multi-drug resistance, integron and blaESBL gene carriage with genetic fingerprints of extended-spectrum β-lactamase producing Klebsiella pneumoniae. Jundishapur J Microbiol 7(2):e8747

    Article  PubMed Central  PubMed  Google Scholar 

  • Aslam SN, Stevenson PC, Kokubun T et al (2009) Antibacterial and antifungal activity of cicerfuran and related 2-arylbenzofurans and stilbenes. Microbiol Res 165(2):191–195

    Article  Google Scholar 

  • Baines M, Ebringer A, Avakian H et al (1990) The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the cross-reactivity of Klebsiella antigens and HLA-B27 in ankylosing spondylitis patients and healthy controls. Scand J Rheumatol 19:341–349

    Article  CAS  PubMed  Google Scholar 

  • Blankenberg-Sprenkels SD, Fielder M, Feltkamp TW et al (1998) Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis. J Rheumatol 25:743–747

    CAS  PubMed  Google Scholar 

  • Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379–1390

    Article  PubMed  Google Scholar 

  • Braun J, Bollow M, Remlinger G et al (1998) Prevalence of spondylarthropathies in HLA B27-positive and negative blood donors. Arthritis Rheum 41:58–67

    Article  CAS  PubMed  Google Scholar 

  • Braun J, Baraliakos X, Listing J et al (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and entanercept. Arthritis Rheum 52(8):2447–2451

    Article  CAS  PubMed  Google Scholar 

  • Braun J, van den Berg R, Baraliakos X et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chou CT, Uksila J, Toivanen P (1998) Enterobacterial antibodies in Chinese patients with rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 16:161–164

    CAS  PubMed  Google Scholar 

  • Cock IE (2008) Assessment of the toxicity of selected Australian native plant extracts using the Artemia franciscana nauplii bioassay. Internet J Toxicol 5(2)

  • Cock IE (2009) Antibacterial activity of Eucalyptus major and Eucalyptus baileyana methanolic extracts. Internet J Microbiol 6(1)

  • Cock IE, Kukkonen L (2011) An examination of the medicinal potential of Scaevola spinescens: toxicity, antibacterial and antiviral activities. Pharmacog Res 3(2):85–94

    Article  Google Scholar 

  • Cock IE, Mohanty S (2011) Evaluation of the antibacterial activity and toxicity of Terminalia ferdinandiana fruit extracts. Pharmacog J 3(20):72–79

    Article  Google Scholar 

  • Cock IE, van Vuuren SF (2014) Anti-Proteus activity of some South African medicinal plants: their potential for the prevention of rheumatoid arthritis. Inflammopharmacology 22:23–36. doi:10.1007/s10787-013-0179-3

    Article  CAS  PubMed  Google Scholar 

  • Ebringer A, Rashid T, Wilson C et al (2006) Ankylosing spondylitis as an auto-immune disease linked to intestinal Klebsiella infection: prospects for a new therapeutic approach. Curr Rheumatol Rev 2:55–68

    Article  CAS  Google Scholar 

  • Elmali N, Baysal O, Harma A et al (2007) Effects of resveratrol in inflammatory arthritis. Inflammation 30:1–6

    Article  CAS  PubMed  Google Scholar 

  • Fielder M, Pirt SJ, Tarpey I et al (1995) Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. FEBS Lett 369:243–248

    Article  CAS  PubMed  Google Scholar 

  • Huang C, Wang Y, Wang J et al (2013) TSG (2,3,4′,5-tetrahydroxystilbene 2-o-β-d-glucoside) suppresses induction of pro-inflammatory factors by attenuating the binding activity of nuclear factor-κB in microglia. J Neuroinflammation 10:129

    Article  PubMed Central  PubMed  Google Scholar 

  • Jayatilake G, Jayasuriya H, Lee E et al (1993) Kinase inhibitors from Polygonum cuspidatum. J Nat Prod 56(10):1805–1810

    Article  CAS  PubMed  Google Scholar 

  • Joseph CC, Moshi MJ, Innocent E et al (2008) Isolation of a stilbene glycoside and other constituents of Terminalia sericea. African J Trad Comp Med 4(4):383–386

    Google Scholar 

  • Lanzilli G, Cottarelli A, Nicotera et al (2012) Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 35(1):240–248

    Article  CAS  PubMed  Google Scholar 

  • Lawrence RC, Helmick CH, Arnett FC et al (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778–799

    Article  CAS  PubMed  Google Scholar 

  • Maki-Ikola O, Penttinen M, von Essen R et al (1997) IgM, IgG and IgA class enterobacterial antibodies in serum and synovial fluid in patients with ankylosing spondylitis and rheumatoid arthritis. Br J Rheumatol 36:1051–1053

    Article  CAS  PubMed  Google Scholar 

  • Nathisuwan S, Burgess DS, Lewis JS (2001) Extended-spectrum beta-lactamases: epidemiology, detection, and treatment. Pharmacotherapy 21(8):920–928

    Article  CAS  PubMed  Google Scholar 

  • Paulo L, Ferreira S, Gallardo E et al (2010) Antimicrobial activity and effects of resveratrol on human pathogenic bacteria. World J Microbiol Biotechnol 26:1533–1538

    Article  CAS  Google Scholar 

  • Rashid T, Ebringer A (2007) Ankylosing spondylitis is linked to Klebsiella—the evidence. Clin Rheumatol 26:858–864. doi:10.1007/s10067-006-0488-7

    Article  PubMed  Google Scholar 

  • Ruebhart DR, Wickramasinghe W, Cock IE (2009) Protective efficacy of the antioxidants vitamin E and Trolox against Microcystis aeruginosa and Microcystin-LR in Artemia franciscana nauplii. J Toxicol Environ Health Part A 72:1567–1575

    Article  CAS  PubMed  Google Scholar 

  • Sautron C, Cock IE (2014) Antimicrobial activity and toxicity of Syzygium australae and Syzygium leuhmannii fruit extracts. Pharmacog Commn 4(1):53–60

    Article  Google Scholar 

  • Schwimmbeck PL, Yu DTY, Oldstone MBA (1987) Autoanti-bodies to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter’s syndrome: molecular mimicry with Klebsiella pneumoniae as a potential mechanism of autoimmune disease. J Exp Med 166:173–181

    Article  CAS  PubMed  Google Scholar 

  • Sirdaarta J, Cock IE (2008) Vitamin E and TroloxTM reduce toxicity of Aloe barbadensis Miller juice in Artemia franciscana nauplii but individually are toxic at high concentrations. Internet J Toxicol 5(1)

  • Sirdaarta J, Cock IE (2010) Effect of Aloe barbadensis Miller juice on oxidative stress biomarkers in aerobic cells using Artemia franciscana as a model. Phytother Res 24:360–364

    Article  CAS  PubMed  Google Scholar 

  • Tani Y, Tiwana H, Hukuda S et al (1997) Antibodies to Klebsiella, Proteus and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 24:109–114

    CAS  PubMed  Google Scholar 

  • Tiwana H, Wilson C, Walmsley RS et al (1997) Antibody response to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn’s disease and ulcerative colitis. Rheumatol Int 17:11–16

    Article  CAS  PubMed  Google Scholar 

  • Van Wyk BE, van Oudtshoorn B, Gericke N (2009) Medicinal plants of South Africa, 2nd edn. Briza Publications, Pretoria South Africa

    Google Scholar 

  • Vesoul J, Cock IE (2011) An examination of the medicinal potential of Pittosporum phylliraedes: toxicity, antibacterial and antifungal activities. Pharmacog Commn 1(2):8–17

    Article  Google Scholar 

  • Wang WB, Lai HC, Hsueh PR et al (2006) Inhibition of swarming and virulence factor expression in Proteus mirabilis by resveratrol. J Med Microbiol 55:1313–1321

    Article  CAS  PubMed  Google Scholar 

  • Welsh J, Avakian H, Cowling P et al (1980) Ankylosing spondylitis, HLA-B27 and Klebsiella. I: cross-reactivity studies with rabbit antisera. Br J Exp Pathol 61:85–91

    CAS  PubMed Central  PubMed  Google Scholar 

  • Winnett V, Boyer H, Sirdaarta J, Cock IE (2014) The potential of Tasmannia lanceolata as a natural preservative and medicinal agent: antimicrobial activity and toxicity. Pharmacog Commn 4(1):42–52

    Article  Google Scholar 

Download references

Acknowledgments

The authors are most grateful to Andrew Hankey, chief botanist at the Walter Sisulu Botanical Gardens in Johannesburg, South Africa, for providing and identifying the plant materials used in these studies. They also thank Professor Charles de Koning and Myron Johnson of the Dept Chemistry, Witwatersrand University for access to their HPLC and assistance with its operation. Financial support was provided by the Department of Pharmacy and Pharmacology, University of the Witwatersrand, South Africa.

Author information

Authors and Affiliations

  1. Environmental Futures Research Institute, Griffith University, 170 Kessels Rd, Nathan, QLD, 4111, Australia

    I. E. Cock

  2. School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, QLD, 4111, Australia

    I. E. Cock

  3. Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, Parktown, 2193, Gauteng, South Africa

    S. F. van Vuuren

Authors
  1. I. E. Cock
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. F. van Vuuren
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. E. Cock.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cock, I.E., van Vuuren, S.F. The potential of selected South African plants with anti-Klebsiella activity for the treatment and prevention of Ankylosing spondylitis. Inflammopharmacol 23, 21–35 (2015). https://doi.org/10.1007/s10787-014-0222-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-014-0222-z

Keywords

search

Navigation